Titre : Fibrillines

Fibrillines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Observer Variation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Fibrillines : Questions médicales les plus fréquentes", "headline": "Fibrillines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Fibrillines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-24", "dateModified": "2025-04-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Fibrillines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines de la matrice extracellulaire", "url": "https://questionsmedicales.fr/mesh/D016326", "about": { "@type": "MedicalCondition", "name": "Protéines de la matrice extracellulaire", "code": { "@type": "MedicalCode", "code": "D016326", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.860.300" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Fibrilline-1", "alternateName": "Fibrillin-1", "url": "https://questionsmedicales.fr/mesh/D000071838", "about": { "@type": "MedicalCondition", "name": "Fibrilline-1", "code": { "@type": "MedicalCode", "code": "D000071838", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.860.300.400.500" } } }, { "@type": "MedicalWebPage", "name": "Fibrilline-2", "alternateName": "Fibrillin-2", "url": "https://questionsmedicales.fr/mesh/D000071840", "about": { "@type": "MedicalCondition", "name": "Fibrilline-2", "code": { "@type": "MedicalCode", "code": "D000071840", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.860.300.400.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Fibrillines", "alternateName": "Fibrillins", "code": { "@type": "MedicalCode", "code": "D000071837", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Dieter P Reinhardt", "url": "https://questionsmedicales.fr/author/Dieter%20P%20Reinhardt", "affiliation": { "@type": "Organization", "name": "Faculty of Medicine, Department of Anatomy and Cell Biology, McGill University, Montreal, Canada. dieter.reinhardt@mcgill.ca." } }, { "@type": "Person", "name": "Clair Baldock", "url": "https://questionsmedicales.fr/author/Clair%20Baldock", "affiliation": { "@type": "Organization", "name": "Division of Cell-Matrix Biology and Regenerative Medicine, Wellcome Centre for Cell-Matrix Research, The University of Manchester, Manchester, UK." } }, { "@type": "Person", "name": "Gerhard Sengle", "url": "https://questionsmedicales.fr/author/Gerhard%20Sengle", "affiliation": { "@type": "Organization", "name": "Center for Biochemistry, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Department of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Cologne Center for Musculoskeletal Biomechanics (CCMB), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany." } }, { "@type": "Person", "name": "Stuart A Cain", "url": "https://questionsmedicales.fr/author/Stuart%20A%20Cain", "affiliation": { "@type": "Organization", "name": "Division of Cell-Matrix Biology and Regenerative Medicine, Wellcome Centre for Cell-Matrix Research, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom." } }, { "@type": "Person", "name": "Muthu L Muthu", "url": "https://questionsmedicales.fr/author/Muthu%20L%20Muthu", "affiliation": { "@type": "Organization", "name": "Faculty of Medicine, Department of Anatomy and Cell Biology, McGill University, Montreal, Canada." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Inter-observer variability of expert-derived morphologic risk predictors in aortic dissection.", "datePublished": "2022-08-27", "url": "https://questionsmedicales.fr/article/36029344", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00330-022-09056-z" } }, { "@type": "ScholarlyArticle", "name": "Inter-observer Variability of Clinical Activity Score: Assessments in Patients With Thyroid Eye Disease.", "datePublished": "2023-04-06", "url": "https://questionsmedicales.fr/article/37028695", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajo.2023.03.027" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of validity and reliability of video analysis and live observations to assess trauma team performance.", "datePublished": "2022-07-11", "url": "https://questionsmedicales.fr/article/35817942", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00068-022-02004-y" } }, { "@type": "ScholarlyArticle", "name": "Intra- and inter-observer agreement in distal radius fracture dislocation measurement of casting position.", "datePublished": "2023-07-21", "url": "https://questionsmedicales.fr/article/37493603", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2340/17453674.2023.13707" } }, { "@type": "ScholarlyArticle", "name": "The effect of a training webinar on decreasing inter-observer variability in making a radiologic diagnosis of bronchiectasis.", "datePublished": "2022-08-24", "url": "https://questionsmedicales.fr/article/36002806", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12880-022-00878-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Scléroprotéines", "item": "https://questionsmedicales.fr/mesh/D012596" }, { "@type": "ListItem", "position": 5, "name": "Protéines de la matrice extracellulaire", "item": "https://questionsmedicales.fr/mesh/D016326" }, { "@type": "ListItem", "position": 6, "name": "Fibrillines", "item": "https://questionsmedicales.fr/mesh/D000071837" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Fibrillines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Fibrillines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Fibrillines", "description": "Comment diagnostiquer une déficience en fibrilline ?\nQuels examens sont utilisés pour évaluer les fibrillines ?\nLes tests génétiques sont-ils fiables pour les fibrillines ?\nQuels symptômes indiquent un problème de fibrilline ?\nPeut-on détecter des anomalies fibrillaires par imagerie ?", "url": "https://questionsmedicales.fr/mesh/D000071837?mesh_terms=Observer+Variation&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Fibrillines", "description": "Quels sont les symptômes d'une maladie liée aux fibrillines ?\nLes douleurs articulaires sont-elles liées aux fibrillines ?\nY a-t-il des signes cutanés associés aux fibrillines ?\nLes problèmes oculaires sont-ils fréquents avec les fibrillines ?\nComment les anomalies cardiovasculaires se manifestent-elles ?", "url": "https://questionsmedicales.fr/mesh/D000071837?mesh_terms=Observer+Variation&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Fibrillines", "description": "Peut-on prévenir les maladies liées aux fibrillines ?\nY a-t-il des conseils de mode de vie pour les patients fibrillaires ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nComment le suivi médical aide-t-il les patients ?\nLes activités physiques sont-elles sûres pour les patients ?", "url": "https://questionsmedicales.fr/mesh/D000071837?mesh_terms=Observer+Variation&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Fibrillines", "description": "Quels traitements existent pour les troubles des fibrillines ?\nLa chirurgie est-elle nécessaire pour les problèmes de fibrillines ?\nDes médicaments peuvent-ils aider les patients fibrillaires ?\nY a-t-il des thérapies spécifiques pour les fibrillines ?\nComment gérer les douleurs liées aux fibrillines ?", "url": "https://questionsmedicales.fr/mesh/D000071837?mesh_terms=Observer+Variation&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Fibrillines", "description": "Quelles sont les complications possibles des troubles fibrillaires ?\nLes complications cardiovasculaires sont-elles fréquentes ?\nComment prévenir les complications liées aux fibrillines ?\nLes douleurs chroniques sont-elles une complication courante ?\nLes problèmes respiratoires peuvent-ils être liés aux fibrillines ?", "url": "https://questionsmedicales.fr/mesh/D000071837?mesh_terms=Observer+Variation&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Fibrillines", "description": "Quels sont les facteurs de risque pour les troubles des fibrillines ?\nLes antécédents familiaux augmentent-ils le risque ?\nLes mutations génétiques sont-elles un facteur de risque ?\nLes conditions médicales préexistantes influencent-elles le risque ?\nL'âge est-il un facteur de risque pour les troubles fibrillaires ?", "url": "https://questionsmedicales.fr/mesh/D000071837?mesh_terms=Observer+Variation&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en fibrilline ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests génétiques et des examens cliniques." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer les fibrillines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie, l'IRM et les tests sanguins peuvent être utilisés." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils fiables pour les fibrillines ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques sont très fiables pour identifier les mutations des fibrillines." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème de fibrilline ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des douleurs articulaires et des anomalies cardiovasculaires peuvent indiquer un problème." } }, { "@type": "Question", "name": "Peut-on détecter des anomalies fibrillaires par imagerie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'imagerie peut révéler des anomalies dans les tissus conjonctifs." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une maladie liée aux fibrillines ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs articulaires, des problèmes cardiaques et des anomalies oculaires." } }, { "@type": "Question", "name": "Les douleurs articulaires sont-elles liées aux fibrillines ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs articulaires peuvent être un signe de dysfonctionnement des fibrillines." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés aux fibrillines ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes cutanés comme des vergetures peuvent être observés en cas de déficience en fibrilline." } }, { "@type": "Question", "name": "Les problèmes oculaires sont-ils fréquents avec les fibrillines ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes comme le décollement de la rétine peuvent survenir." } }, { "@type": "Question", "name": "Comment les anomalies cardiovasculaires se manifestent-elles ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent se manifester par des dilatations aortiques ou des ruptures vasculaires." } }, { "@type": "Question", "name": "Peut-on prévenir les maladies liées aux fibrillines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un suivi médical régulier peut aider à détecter les problèmes tôt." } }, { "@type": "Question", "name": "Y a-t-il des conseils de mode de vie pour les patients fibrillaires ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est recommandé." } }, { "@type": "Question", "name": "Les tests génétiques peuvent-ils aider à la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier les personnes à risque et permettre une surveillance précoce." } }, { "@type": "Question", "name": "Comment le suivi médical aide-t-il les patients ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le suivi médical permet de surveiller l'évolution de la maladie et d'ajuster les traitements." } }, { "@type": "Question", "name": "Les activités physiques sont-elles sûres pour les patients ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des activités physiques modérées sont généralement sûres, mais doivent être adaptées à chaque patient." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles des fibrillines ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la surveillance, la chirurgie et des médicaments pour gérer les symptômes." } }, { "@type": "Question", "name": "La chirurgie est-elle nécessaire pour les problèmes de fibrillines ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie peut être nécessaire pour corriger des anomalies cardiovasculaires graves." } }, { "@type": "Question", "name": "Des médicaments peuvent-ils aider les patients fibrillaires ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments peuvent aider à gérer les symptômes et à prévenir les complications." } }, { "@type": "Question", "name": "Y a-t-il des thérapies spécifiques pour les fibrillines ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de thérapie spécifique, mais des soins symptomatiques sont offerts." } }, { "@type": "Question", "name": "Comment gérer les douleurs liées aux fibrillines ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La gestion de la douleur peut inclure des analgésiques et des thérapies physiques." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des troubles fibrillaires ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des ruptures vasculaires, des problèmes cardiaques et des douleurs chroniques." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles fréquentes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications cardiovasculaires sont courantes et peuvent être graves." } }, { "@type": "Question", "name": "Comment prévenir les complications liées aux fibrillines ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier et un traitement approprié peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Les douleurs chroniques sont-elles une complication courante ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les douleurs chroniques peuvent survenir et nécessitent une gestion adéquate." } }, { "@type": "Question", "name": "Les problèmes respiratoires peuvent-ils être liés aux fibrillines ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes respiratoires peuvent survenir en raison de complications pulmonaires." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles des fibrillines ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des conditions médicales." } }, { "@type": "Question", "name": "Les antécédents familiaux augmentent-ils le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un historique familial de troubles fibrillaires augmente le risque de développer la maladie." } }, { "@type": "Question", "name": "Les mutations génétiques sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines mutations génétiques sont directement liées aux troubles des fibrillines." } }, { "@type": "Question", "name": "Les conditions médicales préexistantes influencent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions comme le syndrome de Marfan augmentent le risque de complications." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour les troubles fibrillaires ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "L'âge peut influencer la gravité des symptômes, mais n'est pas un facteur de risque direct." } } ] } ] }

Sources (10000 au total)

Inter-observer variability of expert-derived morphologic risk predictors in aortic dissection.

Establishing the reproducibility of expert-derived measurements on CTA exams of aortic dissection is clinically important and paramount for ground-truth determination for machine learning.... Four independent observers retrospectively evaluated CTA exams of 72 patients with uncomplicated Stanford type B aortic dissection and assessed the reproducibility of a recently proposed combination o... Pre-training ICCs of the four morphologic features ranged from 0.04 (-0.05 to 0.13) to 0.68 (0.49-0.81) between observer 1 and observers 2-4 and from 0.50 (0.32-0.69) to 0.89 (0.78-0.95) between obser... Manual morphologic feature measurements on CTA images can be optimized resulting in improved inter-observer reliability. This is essential for robust ground-truth determination for machine learning mo... • Clinical fashion manual measurements of aortic CTA imaging features showed poor inter-observer reproducibility. • A standardized workflow with standardized training resulted in substantial improveme...

Inter-observer Variability of Clinical Activity Score: Assessments in Patients With Thyroid Eye Disease.

Thyroid eye disease (TED) can be difficult to manage. The range of available treatments is expanding rapidly; however, cost is a concern and some patients do not respond. The Clinical Activity Score (... Prospective reliability analysis.... Nine patients with a spectrum of clinical features of TED were assessed by 6 experienced observers on the same day. Agreement among the observers was analyzed using the Krippendorff alpha.... The Krippendorff alpha for the total CAS was 0.532 (95% CI = 0.199-0.665), whereas alpha values for the individual components of the CAS varied between 0.171 (CI = 0.000-0.334) for lid redness and 0.6... This study has shown unreliable inter-observer variability in total CAS and most individual CAS components, thus highlighting the need for improving the performance of the CAS or seeking other methods...

Evaluation of validity and reliability of video analysis and live observations to assess trauma team performance.

A trauma resuscitation is dynamic and complex process in which failures could lead to serious adverse events. In several trauma centers, evaluation of trauma resuscitation is part of a hospital's qual... In this prospective observational study, validity was assessed by comparing the observed adherence to 28 advanced trauma life support (ATLS) guideline related tasks by video analysis to life observati... Eleven simulated and thirteen real-life resuscitations were assessed. Overall, the percentage of observed ATLS related tasks performed during simulated resuscitations was 10.4% (P < 0.001) higher when... Video analysis of trauma resuscitations may be more valid and reliable compared to evaluation by live observers. These outcomes may guide the debate to justify video review instead of live observation...

Intra- and inter-observer agreement in distal radius fracture dislocation measurement of casting position.

Most displaced distal radius fractures (DRF) are treated nonoperatively, with reduction and immobilization in a cast. Studies assessing intra- or inter-observer agreement on radiologic measurements of... Our study is based on the Kuopio Osteoporosis Risk Factor and Prevention (OSTPRE) study. All detected DRFs during the OSTPRE follow-up were retrieved and based on sample size calculations 50 fractures... For radial inclination, radial shortening, and dorsal/volar tilt, intra- and inter-observer correlations were high (CCC > 0.76). In addition, measurements of wrist angle in a splint had high correlati... Intra- and inter-observer repeatability of casting position of radial inclination, radial shortening, and dorsal/volar tilt were high whereas intra-articular gap and step had poor correlations....

Inter-observer agreement in grading severity of diabetic retinopathy in wide-field fundus photographs.

To examine the inter-observer agreement between two retina specialists in grading diabetic retinopathy (DR) severity in ultra-wide-field fundus photographs.... Two hundred and seventy patients with diabetes, who visited the vitreoretinal specialty at a tertiary eye care hospital, with or without DR underwent comprehensive ophthalmic examination, dilated reti... The two graders showed agreement in 229/270 images (84.8%) and disagreement in 41/270 images (15.2%). The unweighted kappa for agreement between graders was k = 0.715, SE = 0.037 and the weighted kapp... The impact of disagreement noted between observers in grading DR on UWF fundus photographs should be considered when utilizing UWF system in clinical studies....

Comparison of supervised-learning approaches for designing a channelized observer for image quality assessment in CT.

The current paradigm for evaluating computed tomography (CT) system performance relies on a task-based approach. As the Hotelling observer (HO) provides an upper bound of observer performances in spec... Here we investigated the efficiency of a supervised ML-algorithm used to design a CO for predicting the performance of unconstrained HO. The ML-algorithm was applied either (1) in the estimator for di... A channelized support vector machine (CSVM) was employed and compared against the CHO in terms of ability to predict HO performances. Both the CSVM and the CHO were estimated with channels derived fro... The CSVM outperformed the CHO for all types of channels and regularization strategies. Furthermore, even though both COs generalized well to images reconstructed with the same regularization strategy ... These results argue for introducing the supervised-learning paradigm in the detector function rather than in the operator of the channels when designing a CO to provide an accurate estimate of HO perf...

Impact of metal artifact reduction algorithm on gross tumor volume delineation in tonsillar cancer: reducing the interobserver variation.

Patients with tonsillar cancer (TC) often have dental fillings that can significantly degrade the quality of computed tomography (CT) simulator images due to metal artifacts. We evaluated whether the ... Eighteen patients with TC with dental fillings were enrolled in this study. Contrast-enhanced CT simulator images were reconstructed using the conventional (CT... GTV... The use of the MAR algorithm led to the delineation of smaller GTVs and reduced interobserver variations in delineating GTV of the primary tumors in patients with TC....